All patients tolerated treatment well, no toxicity at level 4. Rectal inflammation caused by radiation at level 1 - 2 accounts for 27.4% (20/73) and at level 3 accounts for 1.3% with 1 case, dermatitis due to radiation at level 1 - 2 accounts for 30.1% (22/73), fatigue at level 1 - 2 accounts for 17.8% (13/73), urinary tract inflammation at level 1 accounts for 8.2% (6/73), weight loss accounts for 9.6% (7/73).